S. Haslund-Krog

Variation in Extemporaneous Glucocorticoid Formulations and Doses for Asthma-like Symptoms in Children

H. Holst, M. Schmidt, S. Haslund-Krog, 2019, Journal of Pediatrics, Perinatology and Child Health.

Acceptability of Prednisolone in an Open-Label Randomised Cross-Over Study—Focus on Formulation in Children

K. Dalhoff, I. M. Jørgensen, H. Holst, 2022, Children.

Challenges in conducting paediatric trials with off-patent drugs

J. N. van den Anker, K. Dalhoff, H. Holst, 2021, Contemporary clinical trials communications.

Interventional cohort study of prolonged use (>72 hours) of paracetamol in neonates: protocol of the PARASHUTE study

J. N. van den Anker, K. Dalhoff, D. Wilkins, 2019, BMJ Paediatrics Open.

The impact of legislation on drug substances used off-label in paediatric wards—a nationwide study

R. Mathiasen, H. R. Christensen, H. Holst, 2014, European Journal of Clinical Pharmacology.

Pharmacokinetics of prednisolone in children: an open-label, randomised, two-treatment cross-over trial investigating the bioequivalence of different prednisolone formulations in children with airway disease

R. Mathôt, Maria Schmidt, H. Holst, 2019, BMJ Paediatrics Open.

The impact of legislation on drug substances used off-label in paediatric wards—a nationwide study

H. R. Christensen, H. Holst, S. Haslund-Krog, 2014, European Journal of Clinical Pharmacology.

Development of one paediatric and one neonatal formulary list in hospital settings

H. Rolighed Christensen, H. Holst, S. Haslund-Krog, 2018, British journal of clinical pharmacology.

Pharmacokinetics and safety of prolonged paracetamol treatment in neonates: An interventional cohort study

A. Birnbaum, J. N. van den Anker, K. Dalhoff, 2023, British journal of clinical pharmacology.